Gastrointestinal adverse effects are the most common side effects of Wegovy, including nausea, vomiting, diarrhoea, constipation, and abdominal discomfort
In particular, among subjects who received semaglutide, 86% lost 5% or more of baseline weight and half of them obtained a weight reduction of at least 15%
The light signals were subsequently converted to concentrations using standard curves specific to each assay plate
suspected reactions to licensed medicines outside trials can be reported via the MHRA Yellow Card scheme
10.1210/en.2014-1653 Endocrinology 81 JeppesenP
Because of the rapid 30-minute half-life, this application is typically introduced 1 to 3 times daily to maintain meaningful experimental windows